# Presidio Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/presidio-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: San Francisco, US
- Website: www.presidiopharma.com
- Total disclosed funding: $71M
- Latest round: Series D (Apr 16, 2013)
- Investors on record: 9

## About

Founded in 2006 and based in San Francisco, Presidio Pharmaceuticals is a clinical-stage pharmaceutical company dedicated to the discovery and development of small-molecule antiviral therapeutics.

## Funding rounds

- Series D, Apr 16, 2013, $8.6M — Ventures West Capital, Baker Brothers Advisors
- Series C, Nov 2, 2012, $8.4M — Panorama Capital, New Leaf Venture Partners, Baker Brothers Advisors
- Series B, Jun 30, 2009, $27M — Ventures West Capital, Panorama Capital, New Leaf Venture Partners, Bay City Capital, NMT Capital, Baker Brothers Advisors, Sagamore Investments
- Series B, Aug 29, 2007, $26M — Ventures West Capital, Peninsula Ventures, Panorama Capital, Bay City Capital, NMT Capital, Baker Brothers Advisors, Sagamore Investments
- Series A, Jun 9, 2006, $1.4M — Peninsula Capital Partners, Sagamore Investments

## Investors

- Peninsula Capital Partners (https://capitalatlas.ai/funds/peninsula-capital-partners) — Series A
- Sagamore Investments — Series A, Series B
- Ventures West Capital (https://capitalatlas.ai/funds/ventures-west-capital) — Series B, Series D
- Peninsula Ventures (https://capitalatlas.ai/funds/peninsula-ventures) — Series B
- Panorama Capital — Series B, Series C
- Bay City Capital (https://capitalatlas.ai/funds/bay-city-capital) — Series B
- NMT Capital (https://capitalatlas.ai/funds/nmt-capital) — Series B
- Baker Brothers Advisors (https://capitalatlas.ai/funds/baker-brothers-advisors) — Series B, Series C, Series D
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series B, Series C